baber/WOPTO huggingface dataset:
Patent DK-0554381-T3 (DK)
Inventor: WONG GRACE H W
IPC: A61P7/00
Filed: 1991-10-21
Granted: 1996-04-09
Abstract: Use of a protective agent(s) selected from the group of tumor necrosis factor -alpha and -beta, growth hormone, IL-1 and D-factor for the production of a composition suitable for protection, inhibition and prevention of the deleterious effects of reactive oxygen species, and administration of an effective amount of the protective agent(s). Treatment of tissues and organs to be transplanted are described. Perfusion solutions and the preparation of perfused, excised tissue are described.
Patent DK-0499399-T3 (DK)
Inventor: MODY DHIRAJ SHANTILAL
IPC: A61K9/06
Filed: 1992-02-06
Granted: 1997-02-03
Abstract: The invention provides a topical analgesic composition comprising an oil-in-water emulsion containing about 5% to about 12% by weight of ibuprofen and about 60% to about 90% by weight of water, the oil phase of the emulsion consisting essentially of emollient constituents that do not dissolve the ibuprofen to any great extent at a pH of 4-7, the composition having a pH of about 4 to about 7.2 such that the ibuprofen is suspended in substantially solid crystalline form and the ibuprofen which is dissolved is partially in the neutral or non-charged state. The invention also includes a process for preparing this composition.
Patent DK-0612342-T3 (DK)
Inventor: DUAN DANIEL C
IPC: A61K9/70
Filed: 1992-10-30
Granted: 1997-06-16
Abstract: A hydrophilic, pressure-sensitive adhesive composition prepared by irradiating solid poly(N-vinyl lactam) with ionizing radiation to crosslink the poly(N-vinyl lactam) and thereafter mixing the radiation-crosslinked poly(N-vinyl lactam) with essentially unirradiated plasticizer in an amount sufficient to form a cohesive, pressure-sensitive adhesive composition. The composition is useful as a biomedical adhesive for transmitting or receiving electrical signals as a component of a biomedical electrode. The composition is also useful as a drug delivery device to deliver pharmaceuticals or other active ingredients to or through mammalian skin. The composition is also useful as a component in a skin covering for protecting mammalian skin or mammalian skin openings with antimicrobial agents. A method of preparation of the composition is also disclosed.
Patent DK-0600222-T3 (DK)
Inventor: KOENIG RAIMUND
IPC: H01T4/16
Filed: 1993-10-27
Granted: 1996-01-29
Abstract: A spark gap arrangement capable of handling lightning includes a first spark gap with a relatively high-resistance insulating layer having a relatively short spark-over path, and at least one second spark gap which, compared to the first spark gap, has a relatively low-resistance insulating layer with a relatively long spark-over path, the second spark gap being electrically connected in series to the first spark gap.
Patent DK-0559252-T3 (DK)
Inventor: KLOBBIE EDUARD JOHAN GERARD
IPC: D01F6/04
Filed: 1993-02-05
Granted: 1997-11-03
Abstract: Horticultural yarn, made in one of the manners conventional therefor from one or more substances belonging to the group of polyolefins. The yarn material contains a photothermally degradable substance, known per se, i.e., a substance which disintegrates by action of light and/or heat, added, for instance in masterbatch form, to the basic material in such amounts that the yarn is compostable.
Patent DK-0568379-T3 (DK)
Inventor: GUO YILI
IPC: C09K23/00
Filed: 1993-04-29
Granted: 1999-07-19
Abstract: New and improved compositions comprising particulates and an effective amount of one or more effective salt(s) to reduce significantly the wetting time and/or the dispersion time of said particulates relative to said time(s) in the absence of said salt(s) have been discovered. Methods for reducing the wetting time of particulates in liquid have also been discovered.
Patent DK-0623213-T3 (DK)
Inventor: CARR MARCUS E JR
IPC: G01N33/487
Filed: 1993-01-15
Granted: 2000-10-02
Abstract: The performance of platelets can be best understood by monitoring both the force development and the elastic modulus of the blood clot during both clotting and dissolution of the blood clot. Intermittent application and removal of a compressive force on a blood sample (8) positioned between a pair of plates (12 and 14) throughout clot formation and dissolution provides a standard for using voltage output from a transducer (22) to determine force and elastic modulus parameters. Force development arises from the internal actions of the platelets during clot retraction. Elastic modulus provides a measure of the stiffness of the clot. Clotting can be measured as an increase in force development and clot elastic modulus. Clot dissolution can be determined by a dramatic decrease in force development and in elastic modulus. Providing the blood sample with a clot dissolving agent such as tPA allows determining the fibrinolytic potential of whole blood and, thus, aids in identifying patients at risk for thrombosis due to a decreased ability to dissolve clots. Clot elastic modulus provides a measure of erythrocyte flexibility.
Patent DK-0647235-T3 (DK)
Inventor: BUSCH FRANK R
IPC: C07J17/00
Filed: 1993-04-02
Granted: 1997-10-27
Abstract: PCT No. PCT/US93/02812 Sec. 371 Date Dec. 20, 1994 Sec. 102(e) Date Dec. 20, 1994 PCT Filed Apr. 2, 1993 PCT Pub. No. WO94/00479 PCT Pub. Date Jan. 6, 1994Processes for the synthesis of tigogenin beta-O-cellobioside heptaalkanoate which is an intermediate for the known hypo-cholesterolemic agent tigogenin beta-cellobioside. The process comprises reacting  alpha -cellobiosyl bromide heptaalkanoate and  beta -tigogenin in the presence of zinc fluoride or zinc cyanide under conditions capable of forming said tigogenyl  beta -O-cellobioside heptaalkanoate. The analogous preparations of hecogenin  beta -O-cellobioside heptaalkanoate 11-ketotigogenin  beta -O-cellobioside heptaalkanoate, and diosgenin  beta -O-cellobioside heptaalkanoate are also disclosed. The process provides both high  beta -anomeric selectivity and high yields.
Patent DK-0664738-T3 (DK)
Inventor: MOELLER ACHIM
IPC: B27L11/00
Filed: 1993-06-26
Granted: 1996-10-21
Abstract: A recycled wood product is formed from wood products originally made from first cut wood. The recycled wood product is formed by removing external fittings, if any, projecting from the original, wood product and thereafter chipping the original wood product into platelets which are thereafter assembled in layers, glued together and then pressed together. Any excess formaldehyde in the original wood product is removed by the addition of urea. Machinery to practice the process includes a chipping tool which chips the original product into platelets as the original wood product is advanced against the chipping tool on a movable support structure.
Patent DK-0648193-T3 (DK)
Inventor: KLISS HARALD
IPC: C02F11/13
Filed: 1993-07-02
Granted: 1998-09-23
Abstract: PCT No. PCT/EP93/01707 Sec. 371 Date Apr. 11, 1995 Sec. 102(e) Date Apr. 11, 1995 PCT Filed Jul. 2, 1993 PCT Pub. No. WO94/01368 PCT Pub. Date Jan. 20, 1994A process for purifying waste water form a vehicle washing installation and returning the purified water to the installation is described. The process circulates the collected waste water by negative pressure generated by a water jet pump. The pump has a water seal provided by a portion of the water after purifying.
Patent DK-0612212-T3 (DK)
Inventor: LEE JAMES C
IPC: A01N43/78
Filed: 1993-07-30
Granted: 1999-11-01
Abstract: A composition comprising TCMTB and a solid, preferably inert, carrier. The composition is in a powdered form and can be effective for preventing the growth of microorganisms. A method for preparing this composition comprises mixing the TCMTB with the carrier.
Patent DK-0652334-T3 (DK)
Inventor: LETULLE CLAUDE
IPC: E04B2/52
Filed: 1994-09-26
Granted: 1999-08-23
Abstract: The construction according to the invention is produced from prefabricated elements (A, B) stacked, dry, in superposed rows and each including two end faces (1) provided with a recess (2), two longitudinal faces (5, 6), cavities (7) and cells (alveoles) (8) respectively adjacent to the longitudinal faces. It is characterised in that the cells (8) each include a transverse section (8a) extending between two adjacent cavities (7), the transverse sections (8a) emerging on the upper (3) and lower (4) faces and having a cross-section approximately equal to that of a conduit (9) delimited by the recesses (2) of two adjacent elements (A,B) of the same row, in that the conduits (9) are each located in the prolongation of one of the transverse sections (8a) of the cells (8) of one element of the adjacent row and in that a binder is poured (cast) into the conduits (9) and the cells (8). <IMAGE>
Patent DK-0656858-T3 (DK)
Inventor: MORLEY TIMOTHY CORBEN
IPC: B65D81/05
Filed: 1993-08-25
Granted: 1996-12-02
Abstract: PCT No. PCT/GB93/01813 Sec. 371 Date Apr. 10, 1995 Sec. 102(e) Date Apr. 10, 1995 PCT Filed Aug. 25, 1993 PCT Pub. No. WO94/04430 PCT Pub. Date Mar. 3, 1994An edge protector for use in particular on generally flat-faced, panel-like articles such as doors, worktops, tabletops and the like, and to the articles when fitted with the edge protector. The edge protector is of "U-section", the sides of said "U-section" being thinner than the base, the said sides and at least a part of the base being formed from a single length of semi-rigid paper, said base including at least one extra piece of paper located between the said sides, characterised in that the said single length is of corrugated paper and in that the fluting of the corrugations runs laterally around the "U-section".
Patent DK-0744940-T3 (DK)
Inventor: MODI PANKAJ
IPC: A61K9/50
Filed: 1995-02-14
Granted: 1999-07-26
Abstract: A controlled release formulation for use with a variety of drugs, vaccines or hormones are formed in microspherical form. The drug, vaccine or hormone, e.g. bovine somatropine, hepatitis vaccine, is suspended in a polymer matrix. The polymer matrix is formed from at least two water soluble biodegradable polymers, selected for example from starch, crosslinked starch, ficoll, polysucrose, polyvinyl alcohol, gelatine, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl-ethyl cellulose, hydroxypropyl-methyl cellulose, sodium carboxymethyl cellulose, cellulose acetate, sodium alginate, polymaleic anhydride esters, polyortho esters, polyethyleneimine, polyethylene glycol, methoxypolyethylene glycol, ethoxypolyethylene glycol, polyethylene oxide, poly(1,3 bis(p-carboxyphenoxy) propane-co-sebacic anhydride, N,N-diethylaminoacetate, block copolymers of polyoxyethylene and polyoxypropylene. The microspheres are coated with a (d,1 lactide-glycolide) copolymer. The coating makes the microspheres more resistant to enzymatic degradation.
Patent DK-0744957-T3 (DK)
Inventor: EIBL MARTHA PROF
IPC: A61P29/00
Filed: 1995-02-16
Granted: 2000-03-06
Abstract: Inflammation can be treated or prevented altogether by administering a preparation comprising IgA. These preparations also can effect immunomodulation. Preferably, the preparation includes multimeric IgA and is essentially free of IgG in its various forms. Other compounds, such as antibiotics, antiphlogistic agents and antacids, also may be administered. Immunoglobulin A may also be used in vaccines to prevent inflammation. Additionally, an improved assay for evaluating anti-inflammatory activity is provided.
Patent DK-0751837-T3 (DK)
Inventor: SVENSSON SIGFRID
IPC: C09D105/00
Filed: 1995-03-23
Granted: 2001-03-05
Abstract: A protective polysaccharide film containing a buffering agent in an amount which is effective for substantially resisting pH changes due to environmental influence; a solution for the application onto a surface to be protected, comprising: a) a polysaccharide dissolved in an aqueous solvent therefore; and b) a buffering agent, said solution being capable of forming a film on said surface which on swelling or dissolution maintains a substantially constant pH due to environmental influence; and a process for protecting a surface from non-desired contamination and to facilitate the removal of such contamination from said surface, comprising the steps: a) applying a solution according to any of claims 7 to 12 on said surface before being subjected to contamination; b) allowing the applied solution to dry with the formation of a solid film on said surface, said film being capable of substantially resisting pH changes due to environmental influence; c) treating said film with a liquid capable of redissolving the film or providing swelling thereof; and d) removing the undesired contamination by completely or partially removing said film from the surface.
Patent DK-0775651-T3 (DK)
Inventor: BERGHOEFER STEFAN
IPC: B65G51/26
Filed: 1996-11-07
Granted: 2001-03-19
Abstract: The system has a fan to pressurise one end and a transmission tube which may be swung to one of three positions to transmit a container to one or other sending station. The container (2) is driven into the sender tube (7) by a piston (10) and pneumatically transmitted by pressure from a fan (30). An electric motor (14) is able to pivot the entire unit to another sending station or to a third position.
Patent DK-0863718-T3 (DK)
Inventor: GRUNDFEST WARREN S
IPC: A61B5/145
Filed: 1996-11-19
Granted: 2004-01-26
Abstract: A glucose monitor, and related method, determines the concentration of glucose in a sample with water, using a predictive regression model. The glucose monitor illuminates the sample with ultraviolet excitation light that induces the water and any glucose present in the sample to emit return light that includes raman scattered light and glucose emission or fluorescence light. The return light is monitored and processed using a predictive regression model to determine the concentration of glucose in the sample. The predictive regression model accounts for nonlinearities between the glucose concentration and intensity of return light within different wavelength bands at a predetermined excitation light energy or the intensity of return light within a predetermined wavelength band at different excitation energy levels. A fiber-optic waveguide is used to guide the excitation light from a laser excitation source to the sample and the return light from the sample to a sensor.
Patent DK-0794256-T3 (DK)
Inventor: MAGOTA KOJI
IPC: C12N1/19
Filed: 1997-03-04
Granted: 2006-06-12
Abstract: The present invention discloses a method for culturing microorganisms having a methanol metabolic pathway in which an expression unit is introduced that comprises a target gene linked downstream from a promoter that can be induced by methanol; wherein, during the culturing period, and including the period during which methanol is continuously or periodically added, the rate of addition is adjusted to a rate equal to or less than the maximum methanol consumption rate of said microorganisms.
Patent DK-0876152-T3 (DK)
Inventor: THOMAS GRIFFITH R
IPC: C12N15/09
Filed: 1997-01-13
Granted: 2002-08-12
Abstract: The present invention is directed to the surprising and unexpected finding that biologically active thrombopoietin materials can be administered with substantial therapeutic effect at dosage rates commensurate with previously reported administration of such materials, but in a single or low-multiple daily administration. Thus, the predicate of the present invention relates to the reversal of thrombocytopenia by administering to a patient having or in need of such treatment a single or low-multiple daily dose of a therapeutically effective amount of a thrombopoietin. The preferable dose of the active material ranges from about 1 to about 10  mu g/kg body weight.
Patent DK-0937251-T3 (DK)
Inventor: JACKSON MICHAEL R
IPC: G01N33/569
Filed: 1997-08-12
Granted: 2007-02-19
Abstract: A new method to capture, purify and expand antigen-specific T lymphocytes has been developed using magnetic beads coated with recombinant MHC class I molecules. This method was optimized using homogenous populations of naive T cells purified from mice transgenic for the 2C T cell receptor (TCR). These T cells were captured on beads coated with MHC class I molecules and the relevant antigenic peptides. MHC and peptide specificity was confirmed by the usage of irrelevant MHC peptide combinations. An enrichment of 800 to 1600 fold was measured, using 2C T cells mixed with irrelevant T cells, starting from a 2C T cell frequency of 1/3000. The same approach was used to purify antigen-specific CD8<SUP>+</SUP> T cells from total CD8<SUP>+</SUP> T cells from naive mice. The recovered cells could be expanded and specifically kill target cells in vitro; they had a significant effect in vivo as well. We expect this procedure to be suitable to purify and expand in vitro tumor- and virus-specific killer T cells for use in cell therapy.
Patent DK-1004784-T3 (DK)
Inventor: SCHWEIZER FRANK
IPC: B23Q1/26
Filed: 1999-11-05
Granted: 2004-06-01
Abstract: A lifting jack consists of two concentric tubes (1, 2) of different diameter with a power system sliding the tubes with respect to each other along a common longitudinal axis (4). The tubes (1, 2) are separated by a bearing (7) which is fixed to the end of one pipe. The bearing (7) consists of two parts (6, 19) with interfaces (15, 23), one width (B) of which is adjustable.
Patent ES-2277807-T3 (ES)
Title: Vehiculo electrico de movimiento de tierras especialmente para emplazamientos poco ventilados.
Inventor: PASQUINI PAOLO
IPC: E02F9/08
Filed: 2000-02-21
Granted: 2007-08-01
Abstract: Vehículo eléctrico de movimiento de tierras (1), especialmente para emplazamientos poco ventilados, que comprende un dispositivo de accionamiento por motor eléctrico (2) para las ruedas motrices del vehículo, una unidad hidráulica (3) que es accionada por un dispositivo de accionamiento por motor eléctrico adicional (4) para un equipo instalado en el vehículo, al menos dos conjuntos de baterías (5, 6) para dichos dispositivos de accionamiento por motor (2, 4), una unidad de control (7) para conectar dichos dispositivos de accionamiento por motor (2, 4) a dichos dos conjuntos de baterías (5, 6), que está adaptada para conectar los dispositivos de accionamiento por motor individual o simultáneamente a uno o a otro conjunto de baterías o a ambos, y un bastidor de soporte (8) que tiene, en una zona intermedia y dirigida hacia abajo, un túnel (9) para introducir uno de dichos dos conjuntos de baterías, comprendiendo dicho dispositivo de accionamiento por motor (2) para las ruedas motrices una unidad de distribución y reducción (10) de tipo de engranajes que está instalada en un alojamiento (11) que está acoplado rígidamente a dicho bastidor (8) a la parte posterior de dicho túnel (9), dos motores eléctricos (12a, 12b) cuyos cuerpos están fijados a dicho alojamiento (11), un eje de distribución longitudinal anterior (16) y un eje de distribución longitudinal posterior (17) que sobresalen desde dicho alojamiento (11), dos diferenciales (18, 19) acoplados a los extremos de dichos ejes de distribución (16, 17), desde los cuales sobresalen respectivamente un eje anterior (20) y un eje posterior (21) para los respectivos pares de ruedas motrices (22a, 22b, 23a, 23b), estando dotado al menos uno de dichos ejes de elementos de dirección (24, 25), y un conjunto (26) para un soporte oscilante de dicho eje anterior (20) que está fijado a una zona dirigida hacia abajo en un extremo anterior de dicho bastidor de soporte (8).
Patent ES-2199714-T3 (ES)
Inventor: MEYER FRANK DR
IPC: C09K19/04
Filed: 2000-02-23
Granted: 2004-03-01
Abstract: New chiral doping agents (I) comprise dianhydrohexitol derivatives containing at least one polymerizable group.  Chiral doping agents of formula (I) are new.  Z1-Y1-(A1)m-Y2-M-Y3-X-Y4-(A2)n-Y5-Z 2 (I)  A1, A2 = spacers having a chain length of 1-30C;  Y1-Y5 = direct bond, O, S, C(O), C(O)O, OC(O), CH=CHC(O)O, OC(O)O, C(O)N(R), N(R)C(O), CH2O, CH=N, N=CH or N=N;  M = mesogenic group;  R = H or 1-4C alkyl;  Z1, Z2 = H, 1-4C alkyl, polymerizable group (PG) or residue carrying a PG, provided that at least one is a PG or residue carrying a PG;  X = dianhydrosorbitol, dianhydromannitol or dianhydroiditol residue;  m, n = 0 or 1.  An Independent claim is included for cholesteric liquid crystal compositions (A) (which preferably reflect left-circular polarized light in the UV region), comprising at least one chiral liquid crystalline monomer (I) which provides a cholesteric liquid crystalline phase having a pitch of less than 450 nm, optionally mixed with at least one achiral liquid crystalline monomer of formula (II).  Z1-Y1-(A1)m-Y2-M-Y4-(A2)n-Y5-Z2 (II)
Patent ES-2257988-T3 (ES)
Inventor: BROUSEK NORBERT
IPC: G06F13/40
Filed: 2000-08-11
Granted: 2006-08-16
Abstract: Automation device (1) comprises a bus part (2) a bus connection (3) and plug points (7) for attaching modules (8) with bus contacts for connecting the bus connections to the internal bus (4). At least one of the modules (8) is for communicating with the internal bus. The bus part (2) includes a memory (9) that can be written to by the modules (8). Parameters relating to the automation device are stored permanently in memory, so that these are retained, even if a module is exchanged.
Patent ES-2298114-T3 (ES)
Inventor: KOLTER KARL DR
IPC: A61K31/4402
Filed: 2000-11-18
Granted: 2008-05-16
Abstract: A film coating containing polyvinyl acetate and hydrophilic additives is used for masking the flavor of oral administration forms. The film coating consists of: (a) polyvinyl acetate (PVA); (b) hydrophilic additives; (c) usual coating components; and optionally (d) a physiologically compatible acid. Independent claims are also included for the following: (1) oral administration forms comprising a core containing active substance coated with the film coating; and (2) the production of medicament-containing oral administration forms using the film coating.
Patent ES-2218056-T3 (ES)
Inventor: LEIBLING UDO
IPC: F27D25/00
Filed: 2000-12-18
Granted: 2004-11-16
Abstract: The burner nozzle system for the heat exchangers used in cement production comprises mounting boxes (1) in which exchangeable nozzles (12) can be mounted. The boxes are mounted in front of bricks (5) on the furnace side with a gap between the edge (17) of the nozzle and the face (18) of the brick directed towards the furnace.
Patent ES-2211446-T3 (ES)
Inventor: LAYROLLE PIERRE JEAN FRANCOIS
IPC: A61L27/18
Filed: 2000-09-20
Granted: 2004-07-16
Abstract: The invention relates to a method for preparing a ceramic-polymer composite comprising the steps of precipitating a gel of the ceramic from an aqueous solution of the ceramic, mixing the gel with polymer and drying at low temperature.
Patent ES-2251951-T3 (ES)
Inventor: SOIGNEUX JACKY
IPC: B23K11/25
Filed: 2000-12-29
Granted: 2006-05-16
Abstract: During current flow to the electrodes an increasing evolution of a parameter (Cf(t)) representing electrode compression force is compared with first threshold (Cf1), and a decreasing evolution of the parameter (Cf(t)) measured during current flow is compared with second threshold (Cf2) and an anomaly is indicated when it overshoots (Cf2). Supervision of resistance welding of a stack (1) of metal workpieces contained between two electrodes (2a, 2b), in which a compression force is applied to the electrodes by a clamp and a voltage (V(t)) is applied between the electrodes permitting the passage of an electric current (I(t)), comprises at least operations consistent with measuring at least one force parameter (Cf(t)) representing the effort of compression before, during and after the passage of current and comparing an increasing evolution of the measured force parameter (Cf(t)) during the passage of current with a first threshold (Cf1). The process of the invention includes comparing a decreasing evolution of the measured force (Cf(t)) during the passage of current and signaling an anomaly when the amplitude of the decreasing evolution overshoots the second threshold (Cf2).